WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity ...Middle East

WUXI, China, Aug. 4, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi...

Hence then, the article about wuxi xdc achieves gmp release of newly launched dp3 facility at wuxi site scaling further drug product manufacturing capacity was published today ( Tuesday 05/08/2025 - 05:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity )

Also on site :

• Wharton’s great contrarian says AI adoption isn’t an easy way to cut headcount: ‘The key thing … is just how much work is involved in doing it’
• Ex-husband charged in deaths of Monique and Spencer Tepe
• A Red State’s High Court Gave Sam Alito the Dobbs Rejoinder He Deserves